Search results
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 1 day agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 23 hours agoModerna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration's move...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 23 hours agoCAMBRIDGE, MA / ACCESSWIRE / May 10, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it has been notified by the U.S. Food and Drug Administration (FDA) that due to administrative ...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 11 hours agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 22 hours agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 14 hours agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 23 hours agoModerna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 22 hours agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 20 hours agoModerna (NASDAQ:MRNA) shares are down just over 1% in early Friday trading after the company said...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 14 hours agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...